Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Sarcoma × Bevacizumab × 30 days × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Colorectal Neoplasms 32 Carcinoma, Hepatocellular 18 Ovarian Neoplasms 16 Neoplasms 15 Fallopian Tube Neoplasms 13 Endometrial Neoplasms 8 Carcinoma, Non-Small-Cell Lung 7 Liver Neoplasms 6 Brain Neoplasms 6 Neoplasm Metastasis 5 Breast Neoplasms 5 Stomach Neoplasms 4 Glioma 4 Glioblastoma 4 Colonic Neoplasms 4 Biliary Tract Neoplasms 4 Uterine Cervical Neoplasms 3 Triple Negative Breast Neoplasms 3 Squamous Cell Carcinoma of Head and Neck 3 Neoplasms, Nerve Tissue 3 Lung Neoplasms 3 Gastrointestinal Neoplasms 3 Digestive System Neoplasms 3 Carcinoma, Ovarian Epithelial 3 Peritoneal Neoplasms 2 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Pancreatic Neoplasms 2 Neoplasms by Site 2 Melanoma 2 Carcinoma, Renal Cell 2

Interventions

Specimen Handling 9 Magnetic Resonance Spectroscopy 7 Doxorubicin 7 Biopsy 7 Gemcitabine 5 X-Rays 4 Phantoms, Imaging 4 tazemetostat 3 pembrolizumab 3 liposomal doxorubicin 3 Radiotherapy 3 Ifosfamide 3 ulixertinib 2 palbociclib 2 ivosidenib 2 ensartinib 2 Surveys and Questionnaires 2 Standard of Care 2 Radiosurgery 2 Radiation 2 Nuclear Medicine Department, Hospital 2 Nivolumab 2 LY3023414 2 Fluorodeoxyglucose F18 2 Docetaxel 2 Cyclophosphamide 2 Albumin-Bound Paclitaxel 2 trastuzumab deruxtecan 1 toripalimab 1 tipifarnib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01746238 2026-04-17

Bevacizumab/Doxorubicin/Radiation for Sarcoma

Massachusetts General Hospital

Phase 1 Active not recruiting

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡